HeartWare Receives Second Patient Allotment Under Continued Access Protocol For Pivotal U.S. Bridge-To-Transplant Clinical Trial
Source: Medical News Today
Saturday 4th September, 2010
HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced ...
Read the full story at
Medical News Today
Email this story to a friend
Have your say on this story
